The Wall Street Transcript
The Wall Street Transcript - In-Depth Interviews for Investors

Investing in China, East Asia and Other Emerging Markets Report

February 21, 2011

Buy ($175)

Topics covered: Undervalued Asian Companies, Investing in Brazil, Focusing on Real Assets, China's Domestic Markets

Companies covered: Procter & Gamble Company (The) (NYSE:PG), Huntington Bancshares Incorporated (NASDAQ:HBAN), FirstMerit Corporation (NASDAQ:FMER), Fifth Third Bancorp (NASDAQ:FITB), City National Corporation (NYSE:CYN), Bank Of Montreal (NYSE:BMO), Ralph Lauren Corporation (NYSE:RL)

Bottom-up Investing In Asian Companies - Tony Hsu - Dalton Investments Llc
Tony Hsu
Investing In China's Domestic Growth Drivers - Agnes Deng - Baring Asset Management
Agnes Deng
An Absolute-return Approach To Emerging Markets - John Brynjolfsson - Armored Wolf, Llc
John Brynjolfsson
Investing In Asian Markets - Khiem Do - Baring Asset Management
Khiem Do
Investing In The Brazilian Market - Marc Fogassa - Hedgefort Capital Management
Marc Fogassa
Top Company Interviews

Microsoft Corporation
Intel Corporation
Pfizer, Inc.
General Electric Company
Walmart Inc.
International Business Machines Corporation
Citigroup Inc.
Exxon Mobil Corporation
Bank of America Corporation
Dell Inc.
Verizon Communications Inc.
Alphabet Inc

Register for a Free Account to gain greater access to The Wall Street Transcript right now

CEO INTERVIEWS
Interview with the CEO: Pasithea Therapeutics Corp. (NASDAQ:KTTA)
Interview with the CEO: BetterLife Pharma Inc. (OTCMKTS:BETRF)
Interview with the CEO: Cansortium Inc. (OTCMKTS:CNTMF)
SECTOR ROUNDTABLES
Natural Gas Weighs Heavy On E&P Near-Term Prospects
Roundtable Forum:optimism Despite Uncertainty In For-profit Education
Roundtable Forum:a Shift In Focus To Natural Gas From Oil
MONEY MANAGER INTERVIEWS
Profitability Strategy Pays Off for Bank IT Company Q2 Holdings
Three Mid-Cap Names Using Their Balance Sheets to Create Value
Look Beyond Traditional Emerging Markets for More Diversification, Less Risk
ANALYST INTERVIEWS
Five Companies Dominate in Psychedelics-Based Drug Development
Cidara’s Long-Acting Antiviral Drug Could Be a Game Changer
Spotting Potential in the High-Risk, High Reward Neuroscience Space
Since 1963
© The Wall Street Transcript 2016, 2024
Terms and Conditions
Privacy Policy